Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to HER2-negative Breast Cancer
Related studies linked through entity extraction aliases.
AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Functional Precision Oncology for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
D4 Choline Breast PET/CT
- Status
- COMPLETED
- Phase
- N/A
Sacituzumab Govitecan In TNBC
- Status
- RECRUITING
- Phase
- PHASE2
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
- Status
- RECRUITING
- Phase
- PHASE1
Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 1 Study of [225Ac]-FPI-1434 Injection
- Status
- TERMINATED
- Phase
- PHASE1
ANG1005 in Leptomeningeal Disease From Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China
- Status
- COMPLETED
- Phase
- PHASE2
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
- Status
- UNKNOWN
- Phase
- PHASE2
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neuropathy in Japan.
- Status
- COMPLETED
- Phase
- N/A
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Everolimus Beyond Progression
- Status
- TERMINATED
- Phase
- PHASE2